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Interleukin  10  (IL-10)  and  regulatory  T  cells  (Tregs)  maintain  tolerance  to  intestinal 
microorganisms. However, Il10 − / − Rag2 − / −  mice, which lack IL-10 and Tregs, remain healthy, 
suggesting the existence of other mechanisms of tolerance. Here, we identify suppressor of 
cytokine signalling 1 (soCs1) as an essential mediator of immune tolerance in the intestine. 
Socs1 − / − Rag2 − / −   mice  develop  severe  colitis,  which  can  be  prevented  by  the  reduction  of 
microbiota and the transfer of IL-10-sufficient Tregs. Additionally, we find an essential role for 
prostaglandin E2 (PGE2) in the maintenance of tolerance within the intestine in the absence of 
Tregs. Socs1 − / −  dendritic cells are resistant to PGE2-mediated immunosuppression because of 
dysregulated cytokine signalling. Thus, we propose that soCs1 and PGE2, potentially interacting 
together, act as an alternative intestinal tolerance mechanism distinct from IL-10 and Tregs. 
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S
everal mechanisms, including immunoregulation by the innate 
and adaptive immune systems, allow for millions of bacteria to 
symbiotically reside in the gastrointestinal tract without dis-
ruption of gut homeostasis. Breakdown of tolerance to intestinal 
microorganisms could have a fundamental role in the pathogenesis 
of inflammatory bowel disease (IBD). Previous studies of several 
genetically engineered mouse models have shown that lack of immu-
nosuppression leads to colitis, for example, Il2 − / −  and Il10 − / − , and 
dominant-negative transforming growth factor-β (TGF-β) type 2   
receptor  transgenic  (Tg)  mice  develop  spontaneous  colitis1.  The   
major targets of interleukin 2 (IL-2) and TGF-β are T cells: TGF-β 
suppresses the growth of T cells and their differentiation into Th1 
and Th2 cell subsets2, and both TGF-β and IL-2 are required for the 
induction, maintenance or function of Foxp3-expressing regulatory   
T  cells3  (Foxp3 + Tregs,  hereafter  referred  to  as  Tregs).  IL-10,  on 
the other hand, suppresses the activation of innate immune cells in 
response to various Toll-like receptor stimuli through a transcription 
factor signal transducer and activator of transcription 3 (STAT3)4.
The Tregs constitute a distinct population of CD4 +  T cells that 
have an essential role in the maintenance of systemic tolerance. 
Alterations in Treg function lead to the activation of T-helper cell 
subsets known as Th1, Th2 and Th17, which produce the cytokines 
interferon-γ (IFNγ), IL-4 and IL-17, respectively, as well as to various 
types of systemic inflammation including inflammation of the gut. 
However, Rag1 − / −  mice lacking Tregs do not develop colitis spon-
taneously. Furthermore, Tgfb1 − / − Rag2 − / −  and Stat3 − / − Rag2 − / −  mice 
do not develop colitis despite their lack of Tregs, TGF-β and IL-10 
signalling5,6. Therefore, another tolerance mechanism, in addition to 
TGF-β and IL-10, must exist in the innate immune system.
Many inflammatory cytokines use the janus kinase (JAK)/STAT 
signalling pathway, which is strictly regulated by negative regulatory 
mechanisms that limit excessive signalling. Two particularly impor-
tant players in this negative regulation are the proteins known as sup-
pressor of cytokine signalling 1 (SOCS1) and SOCS3. SOCS1 regu-
lates the signals of various cytokines such as IFNγ, IL-2, IL-4, and IL-7 
(ref. 7) Socs1 − / −  mice die as early as 2 to 3 weeks after birth as result   
of severe inflammation in the liver8, though they survived much 
longer in the absence of IFNγ or in T-cell-deficient conditions.
In this study, we show that Socs1 − / − Rag2 − / −  mice develop severe 
spontaneous  T-cell-independent  colitis.  Adoptive  transfer  of  IL-
10-sufficient Tregs suppressed the colitis of Socs1 − / − Rag2 − / −  mice, 
suggesting that SOCS1 is necessary to maintain the innate immune 
tolerance in the intestine in the absence of Tregs. IL-10 and IL-
10-sufficient  Tregs  suppressed  the  production  of  inflammatory 
cytokines  from  lipopolysaccharide  (LPS)-stimulated  bone  mar-
row-derived dendritic cells (BMDCs), and Socs1 − / −  BMDCs were as 
sensitive to IL-10-mediated suppression as Socs1 + / +  BMDCs were. 
Therefore, we hypothesized that there is another immunosuppres-
sive  mechanism  in  the  intestinal  innate  immune  system,  whose 
function is impaired in Socs1 − / −  cells, and we sought to identify fac-
tors required for this distinct mechanism of immune suppression. 
Prostaglandin E2 (PGE2) is an IL-10-independent innate immune 
suppressor, and SOCS1-deficiency abolished its immunosuppressive 
effect. Furthermore, deprivation of PGE2 by cyclooxygenase (COX) 
inhibitor provoked severe colitis in Rag2 − / −  but not in Rag2 + / +  mice, 
which was also prevented by the transfer of Tregs. Thus, we propose 
that the tolerance in the intestinal innate immune system is regu-
lated by a unique mechanism involving PGE2, the suppressive effect 
of which could be overridden by inflammatory cytokine signalling, 
which is strictly regulated by SOCS1.
Results
Socs1 − / − Rag2 − / −  mice develop spontaneous colitis. Socs1 − / −  mice 
die shortly after birth as result of severe systemic inflammation8. It 
has been shown that early lethality can be reverted by crossing with 
Ifng − / −  mice, Tcra − / −  mice or Rag2 − / −  mice, or by restoring SOCS1 
expression in T and B cells by crossing with T- and B-cell-specific 
Socs1 Tg mice (Socs1-KOTg mice)8–11. Figure 1a shows the course of 
survival of various Socs1 − / −  mice in our facility. These data suggest 
that dysregulation of IFNγ signalling and activation of lymphocytes 
are the main causes of the early lethality in Socs1 − / −  mice. We have 
previously shown that Socs1 − / − Tcra − / −  mice developed more severe 
colitis than Tcra − / −  mice11. We suspected that SOCS1 deficiency 
in T cells might contribute to the development of colitis; however, 
we later found that Socs1-KOTg mice, in which SOCS1 expression 
is  restored  in  T  cells,  also  developed  mild  colitis  with  age12. 
Furthermore, we found that Socs1 − / − Rag2 − / −  mice developed fatal 
colitis (Fig. 1). These observations suggest that SOCS1 expression in 
cells other than T cells is important in suppression of colitis.
Socs1 − / − Rag2 − / −  mice showed marked growth retardation, but 
survived for up to 4 or 5 months after birth (Fig. 1a and b). All 
Socs1 − / − Rag2 − / −  mice developed severe colitis at 8–9 weeks of age, 
suffering from diarrhoea and weight loss, whereas littermate Rag2 − / −  
mice housed in the same cage never developed colitis (Fig. 1b–d). 
Through histological examination, we observed many mononuclear 
and polymorphonuclear cells infiltrating the lamina propria of the 
large intestines of Socs1 − / − Rag2 − / −  mice (Fig. 1c). The inflammation 
extended from the caecum to the rectum, accompanied by the elon-
gation of the crypts, goblet cell depletion and crypt abscesses, all of 
which are characteristic of chronic colitis.
Flow cytometric analyses showed that CD11bhigh cells and natu-
ral killer cells were predominant in the spleens of both Rag2 − / −  and 
Socs1 − / − Rag2 − / −  mice (Fig. 1e). There was an increase in CD11bhigh 
cells and Gr-1 +  cells in Socs1 − / − Rag2 − / −  mice, probably reflecting 
granulocytosis caused by active colitis. Immunohistochemical exam-
ination showed massive infiltration of CD45 +  cells in the lamina pro-
pria of Socs1 − / − Rag2 − / −  mice (Fig. 1f). Most of these infiltrating cells 
were also stained with anti-CD11b or NK1.1, both of which stained 
significantly more cells in Socs1 − / − Rag2 − / −  colons than in Rag2 − / −  
colons (Fig. 1f). mRNA levels of most of the inflammatory cytokines 
were upregulated in the colons of Socs1 − / − Rag2 − / −  mice (Fig. 1g).
To determine the source of these cytokines, we sorted CD11bhigh 
NK1.1 −   and  CD11blowNK1.1 +   cells,  and  performed  quantitative 
reverse transcription PCR (Fig. 1h). IL-12p35 and IL-6 were pro-
duced  almost  exclusively  by  the  CD11b +   cells,  whereas  tumour 
necrosis  factor-α  (TNFα)  was  produced  by  both  CD11b +   and 
NK1.1 +   cells  (Fig.  1h).  The  expression  levels  of  these  cytokines 
were upregulated in the Socs1 − / −  group. IFNγ was produced only by 
NK1.1 +  cells. NK1.1 +  cells also expressed small amounts of IL-17A 
and IL-4. The production of IL-17 from NK1.1 +  cells has also been 
reported by Passos et al.13. Although the expression levels of IFNγ, 
IL-4 and IL-17A were upregulated in the colons of Socs1 − / − Rag2 − / −  
mice (Fig. 1g), the expression levels of these cytokines per cell in 
Socs1 − / −  NK1.1 +  cells were similar to or less than those in Socs1 + / +  
NK1.1 +  cells (Fig. 1h). Therefore, the upregulation of these cytokines 
in the tissue seemed to be due to the increase in the number of infil-
trating cells. Western blot analyses showed that phosphorylation 
of STAT1 and IκBα was significantly augmented in the colons of 
Socs1 − / − Rag2 − / −  mice, suggesting the activation of JAK/STAT1 and 
nuclear factor-κB pathways in these mice (Fig. 1i).
Characterization of the colitis of Socs1 − / − Rag2 − / −  mice. Socs1 − / −  
Rag2 − / −  mice treated with broad-spectrum antibiotics from 6 weeks 
of age never developed colitis even at 9 weeks of age. Furthermore, 
colitis was markedly improved by antibiotic treatment even after it 
had developed (Fig. 2a). These observations suggest that Socs1 − / −  
intestinal innate immune cells were highly activated by intestinal 
commensal bacteria, resulting in the production of inflammatory 
cytokines, which leads to the development of spontaneous colitis.
Because SOCS1 is a strong negative regulator of the IFNγ signal, 
we generated Ifng − / − Socs1 − / − Rag2 − / −  mice to examine the contribu-
tion of IFNγ to this colitis. As expected, Ifng deficiency significantly   ARTICLE     
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reduced the severity of colitis induced by Socs1/Rag2 deficiency   
(Fig. 2b). However, Ifng deficiency did not eliminate colitis com-
pletely, suggesting that other cytokines that are highly activated in 
Socs1 − / − Rag2 − / −  mice are also involved in colitis. An obvious can-
didate was IL-23. IL-23 is regarded as a key inflammatory factor 
involved in the pathogenesis of colitis14. The involvement of IL-23 
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Figure 1 | Socs1 − / − Rag2 − / −  mice develop spontaneous colitis. (a) The survival curves of Socs1 − / −  (black, n = 5), Socs1 − / − Tcra − / −  (red, n = 14), Socs1 − / −  
Rag2 − / −  (blue, n = 12), Socs1-KoTg (green, n = 6) and Ifng − / − Socs1 − / −  (green, dotted, n = 10) mice. (b) Rag2 − / −  and Socs1 − / − Rag2 − / −  mice (8-week-old; 
upper panel). Representative macroscopic observations of the colons of 9-week-old Rag2 − / −  and Socs1 − / − Rag2 − / −  mice (lower panel). (c) Representative 
histopathology of the colons of Rag2 − / −  (upper left panel) and Socs1 − / − Rag2 − / −  mice (other five panels) at 9 weeks of age stained with haematoxylin and 
eosin. scale bar, 100 µm. (d) The histological scores of colitis for Rag2 − / −  (n = 9) and Socs1 − / − Rag2 − / −  (n = 8) mice at 9 weeks of age. The horizontal lines 
indicate the mean values. (e) Flow cytometric analyses showing the proportions of CD11bhigh and natural killer (nK) (DX5 + ) cells among CD45 + TER119 −  
cells (upper), Gr-1 +  and F4/80 +  cells among CD11b +  cells (middle) and CD11c +  and F4/80 +  cells among CD11b +  cells (lower) in the spleens of Rag2 − / −  
and Socs1 − / − Rag2 − / −  mice. Data are representative of three independent experiments. (f) Fluorescence immunohistochemistry showing the infiltration  
of CD45 +  cells (red) into the colonic lamina propria of Rag2 − / −  (upper left panel) and Socs1 − / − Rag2 − / −  mice (upper right panel). The infiltrating CD45 +  
cells were predominantly CD11b +  cells (green), although nK1.1 +  cells (red) were also significantly increased (lower panels). nuclei of cells are stained  
with Hoechst 33342 dye (blue). Data are representative of three independent experiments using samples from different mice. scale bar, 100 µm.  
(g) RnAs were extracted from the colons of 9-week-old Rag2 − / −  and Socs1 − / − Rag2 − / −  mice, and the indicated gene expression was analysed by RT-PCR. 
Three mice per group are shown. Data are representative of three independent experiments using different samples from one to three mice per group.  
(h) CD11bhighnK1.1 −  and nK1.1 +  cells were sorted by FACsAria from the spleens of Rag2 − / −  and Socs1 − / − Rag2 − / −  mice, and RnA was purified from the cells. 
The relative expression levels of the indicated genes were normalized against Hprt1 using Ct values determined by quantitative real-time RT-PCR. Error 
bars represent  + s.d. of triplicate measurements for each sample. *P < 0.05 and **P < 0.01 compared with Rag2 − / −  cells. Data are representative of two 
independent experiments. (i) Proteins were extracted from the colons of 9-week-old Rag2 − / −  and Socs1 − / − Rag2 − / −  mice, and western blot analyses were 
performed using indicated Abs. Three mice per group are shown. PY, tyrosine phosphorylated; Ps, serine phosphorylated. Data are representative of two 
independent experiments using different samples from two to three mice per group. nD, not determined.ARTICLE
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in the aggravation of colitis in T-cell-deficient mice has also been 
reported  by  previous  studies15,16,  and  the  mRNA  level  of  Il23a 
was increased in the colons of Socs1 − / − Rag2 − / −  mice (Fig. 1g). To 
test the possibility that IL23 was involved in colitis, we generated   
Il23a − / − Socs1 − / − Rag2 − / −  mice. Milder colitis was observed in the 
Il23a − / − Socs1 − / − Rag2 − / −   mice  than  in  the  Socs1 − / − Rag2 − / −   mice 
(Fig. 2b), which supports the idea that not only IFNγ but also IL-23 
is involved in the T-cell-independent development of colitis.
Interestingly,  Ifng − / − Socs1 − / −   mice  never  developed  colitis, 
whereas Ifng − / − Socs1 − / − Rag2 − / −  mice did (Fig. 2b). This suggests that 
the development of colitis caused by SOCS1 deficiency was because 
of the lack of functional T and B cells. These observations strongly 
suggest that lymphocytes have a protective role in the suppression of 
colitis caused by SOCS1 deficiency. Among the lymphocytes, Tregs 
are the most likely to be involved in this process. To explore this 
possibility, we transferred CD4 + CD25high cells from wild-type (WT) 
mice to Socs1 − / − Rag2 − / −  mice. As we expected, there was a marked 
reduction in the severity of colitis in the Treg-transferred group   
(Fig. 2c). In contrast, when we transferred IL-10-deficient Tregs, 
there was no significant improvement, despite the similarity of recon-
stitution rates (Fig. 2d and e). On the basis of these observations,   
we concluded that the lack of Treg-derived IL-10 is an important 
component in the development of colitis in Socs1 − / − Rag2 − / −  mice.
PGE2 as an immunosuppressor molecule in the colonic mucosa. 
Our Treg transfer experiment into Socs1 − / − Rag2 − / −  mice indicated 
that suppression by Treg-derived IL-10 could overwhelm the inflam-
matory effect of SOCS1 deficiency. In accordance with this scenario, 
IL-10 suppressed the TNFα and IL-12p70 production from Socs1 − / −  
BMDCs stimulated with LPS or LPS + IFNγ as efficiently as from 
Socs1 + / +  BMDCs (Fig. 3a, data for LPS alone shown in Supplemen-
tary  Fig.  S1a).  Similarly,  Tregs  suppressed  inflammatory  cytokine 
production from BMDCs in an IL-10-dependent manner and this 
Treg-mediated suppression was also observed in Socs1 − / −  BMDCs 
(Fig. 3b). These observations suggested that IL-10/Treg-mediated 
suppression was not impaired by SOCS1 deficiency; therefore, we 
hypothesized  that  another  immunosuppressive  mechanism  was 
altered in the colons of Socs1 − / − Rag2 − / −  mice.
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Figure 2 | Characterization of the colitis in Socs1 − / − Rag2 − / −  mice. (a) Histological scores of the colitis of 16-week-old Socs1 − / − Rag2 − / −  mice treated 
with or without antibiotics for 2 weeks from 14 weeks of age (n = 3). The horizontal lines indicate the mean values. (b) Histological scores of the colitis of 
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The horizontal lines indicate the mean values. (c) macroscopic and microscopic observations of the colons of Socs1 − / − Rag2 − / −  mice with or without Treg 
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right), and the frequencies of CD4 +  and Foxp3 +  cells among TER119 − CD11c −  cells gated on particular forward and side scatter were analysed. At 6 weeks 
after the transfer, nearly 40% of the CD4 +  cells expressed Foxp3, and the frequency was similar between the Il10 + / +  and Il10 − / −  Treg-transferred group. 
(e) Histological scores of the colitis of 16-week-old Socs1 − / − Rag2 − / −  mice without transfer (black circles, n = 3), transferred with Il10 + / +  Tregs (black 
diamonds, n = 3) and transferred with Il10 − / −  Tregs (black triangles, n = 2) is shown. The horizontal lines indicate the mean values.ARTICLE     
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To define this non-IL-10 tolerance mechanism in the intestine 
and to specifically identify a soluble factor that could suppress the 
immune response, we prepared a whole colonic mucosal extract 
(CME) from the colonic mucosal layer of WT mice and included 
this  CME  in  the  culture  media  for  BMDCs.  Interestingly,  CME 
suppressed  LPS-induced  production  of  IL-12p70  and  TNFα  
from  BMDCs  in  a  dose-dependent  manner  (Fig.  3c).  Because 
this suppression was not counteracted by anti-IL-10-neutralizing   
antibody  (Ab),  IL-10  could  not  be  involved  in  the  suppression   
(Fig. 3c). Importantly, the suppressive effect of CME was diminished   
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Figure 3 | IFNγ renders Socs1 − / −  BMDCs resistant to PGE2 but not to IL-10. (a–e, g, h) Socs1 + / +  (black bars) and Socs1 − / −  (grey bars) BmDCs (5×105 cells 
per ml) induced from the bone marrow cells of Rag2 − / −  and Socs1 − / − Rag2 − / −  mice were stimulated for 12 h with indicated reagents, and the levels of IL-
12p70 and TnFα in the culture supernatant were measured by ELIsA. Error bars represent  + s.d. Cells were stimulated in triplicate wells for each condition 
and s.d. was calculated from the values determined by ELIsA. (a) Socs1 + / +  and Socs1 − / −  BmDCs were stimulated with LPs (10 ng ml − 1) and murine IFnγ 
(10 ng ml − 1) in the presence of graded concentrations of recombinant murine IL-10. (b) Socs1 + / +  and Socs1 − / −  BmDCs were co-cultured with 2.5×105 cells 
per ml of CD4 + CD25high T cells in the presence of soluble anti-CD3 Ab (1 µg ml − 1). Cells were stimulated with LPs + IFnγ (10 ng ml − 1 each) with or without 
anti-IL-10-neutralizing Ab (αIL-10 Ab, 10 µg ml − 1). (c) Socs1 + / +  BmDCs were stimualted with LPs (10 ng ml − 1) in the presence or absence of graded 
concentrations of CmE and αIL-10 Ab (10 µg ml − 1). (d) Socs1 + / +  and Socs1 − / −  BmDCs were stimulated with LPs + IFnγ (10 ng ml − 1 each) in the presence 
of graded concentrations of CmE (v/v, volume of CmE/volume of solution (media + CmE)). **P < 0.01. (e) Socs1 + / +  BmDCs were stimulated with LPs 
(10 ng ml − 1) in the presence or absence of graded concentrations of CmE. The CmE filtrated through Ym-3 ultrafiltration columns (millipore), which 
remove molecules higher than 3,000 Da, retained a suppressive function. IL-10 was used as an experimental control. (f) Tissue extracts from the indicated 
organs were prepared as described in the methods, and the levels of PGE2 were determined by ELIsA. Error bars indicate  + s.d. of triplicate ELIsA 
measurements for each sample. (g) Socs1 + / +  BmDCs were stimulated with LPs (10 ng ml − 1) in the presence of PGE2 (1 nm) or graded concentrations of 
CmE with or without PTGER4 antagonist (ono-AE3-208; 100 nm). (h) Socs1 + / +  and Socs1 − / −  BmDCs were stimulated with LPs + IFnγ (10 ng ml − 1 each)  
in the presence of graded concentrations of PGE2. **P < 0.01. Data are representative of two (f) to three (a–e, g, h) independent experiments.ARTICLE
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in Socs1 − / −  BMDCs but not in Socs1 + / +  BMDCs when cells were 
stimulated with LPS + IFNγ (Fig. 3d, data for LPS alone shown in 
Supplementary Fig. S1b).
In attempting to identify the factor in CME, we noticed that 
the  suppressive  factor  present  in  CME  was  heat  resistant  (Sup-
plementary Fig. S1c), and its molecular weight was estimated to 
be  < 3,000 Da by ultrafiltration (Fig. 3e). Thus, it seemed likely to be 
a small molecule rather than a protein. We had previously purified 
a similar factor from mouse embryonic fibroblast culture media and 
identified it as PGE2 (ref. 13). Therefore, we suspected that the fac-
tor in CME was PGE2; in agreement with this hypothesis, the CME 
contained a large amount of PGE2 (~200 ng ml − 1, as determined   
by enzyme-linked immunosorbent assay (ELISA)). As shown in 
Figure 3f, extracts from the colon, lung and stomach contained 
substantial amounts of PGE2, suggesting that these organs have a 
capacity to produce a relatively large amount of PGE2 compared 
with other organs under physiological conditions. The suppressive 
effect of CME as well as PGE2 was completely counteracted by the 
antagonist of PGE2 receptor 4 (PTGER4, EP4 subtype), a major 
immunoregulatory receptor for PGE2 (ref. 17) (Fig. 3g). These data 
suggested that PGE2 is a major suppressor for proinflammatory 
cytokine production in the intestine, although additional mecha-
nisms of tolerance may also exist. Importantly, just like that of CME, 
the suppressive effect of PGE2 was diminished in Socs1 − / −  BMDCs 
when the cells were stimulated with LPS + IFNγ (Fig. 3h). These data 
indicate that the PGE2-mediated immunosuppressive mechanism 
was impaired in Socs1 − / −  cells.
PGE2 have an indispensable role in the absence of Tregs. Next, 
to confirm that PGE2 has a regulatory role in the intestine in the 
absence  of  Tregs,  we  continuously  administered  the  non-selec-
tive COX inhibitor indomethacin to WT (Rag2 + / + ) and Rag2 − / −  
mice in the drinking water. This treatment effectively suppressed 
the production of PGE2 in the colons of mice of both genotypes   
(Fig. 4a). Interestingly, although indomethacin-administered WT 
mice  rarely  developed  symptoms,  Rag2 − / −   mice  showed  a  high   
susceptibility  to  indomethacin,  and  developed  diarrhoea  and 
weight loss because of severe inflammation in the caecum and colon   
(Fig. 4b) accompanied by elevated levels of inflammatory cytokines 
(Fig. 4c), whereas WT mice developed almost no inflammatory 
changes in the intestine. When a PTGER4 agonist was administered 
together with indomethacin, Rag2 − / −  mice did not develop colitis 
and wasting disease (Fig. 4d), suggesting that the decrease in PGE2/
PTGER4 signalling is the direct cause of indomethacin-induced 
inflammation in Rag2 − / −  mice.
When  commensal  bacteria  were  removed  by  antibiotics, 
indomethacin did not induce colitis in Rag2 − / −  mice (Fig. 4e), sug-
gesting that a dysregulated immune response to commensal bacte-
ria is involved in this colitis. Furthermore, the transfer of Tregs into 
Rag2 − / −  mice also prevented colitis of indomethacin-treated Rag2 − / −  
mice (Fig. 4f). These findings suggest that PGE2-mediated immu-
nosuppression is indispensable for preventing the hyperactivation 
of innate immune cells and the resultant intestinal inflammation 
under Treg-deficient conditions. Interestingly, these features of the 
colitis of indomethacin-treated Rag2 − / −  mice were almost identical 
to those of the colitis observed in Socs1 − / − Rag2 − / −  mice. This was 
consistent with our in vitro observation that the PGE2-mediated 
immunosuppression was impaired in Socs1 − / −  BMDCs.
SOCS1 maintains the immunosuppressive effect of PGE2. We 
attempted to ascertain how the PGE2-mediated immunosuppres-
sion was impaired in Socs1 − / −  BMDCs. As mentioned in Figure 3h, 
the suppressive effect of PGE2 on LPS + IFNγ-induced IL-12p70 
and TNFα production from BMDCs was counteracted by SOCS1 
deficiency, and this antagonism was barely seen in the absence of 
IFNγ, suggesting that dysregulated IFNγ signal is the cause of the 
antagonism. When PGE2 binds to a receptor, especially PTGER4, 
adenylate cyclase is activated and the level of cyclic AMP (cAMP) 
is elevated. cAMP then suppresses the production of inflamma-
tory cytokines by several mechanisms18,19. As shown in Figure 5a, 
Socs1 − / −  BMDCs were also resistant to cAMP-mediated suppres-
sion of cytokine production in the presence of LPS + IFNγ. IFNγ 
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Figure 4 | PGE2-mediated immunosuppression is indispensable for 
Rag2 − / −  but not for WT mice to avoid intestinal inflammation. (a) mice  
(WT (C57BL/6J) and Rag2 − / − ) were fed with or without 40 µg ml − 1 
of indomethacin in drinking water for 3 days. The levels of PGE2 were 
determined by ELIsA. (b) WT (C57BL/6J) and Rag2 − / −  mice were 
continuously administered 40 µg ml − 1 of indomethacin in drinking water. 
Upper panels: Representative macroscopic and microscopic observations of 
the large intestines of the indomethacin-administered WT (upper intestine 
in macroscopic image and lower left section in microscopic image) and 
Rag2 − / −  mice (lower intestine in macroscopic image and lower right 
section in microscopic image). scale bar, 200 µm. Lower panels: The body 
weights (lower left) and survival rates (lower right) of WT (black line) 
and Rag2 − / −  mice (red line) are shown; n = 4 for each group. Error bars 
represent  ± s.d. (c) RnAs were extracted from the proximal colons of the 
indomethacin-administered WT (C57BL/6J) and Rag2 − / −  mice on days 
0, 4 and 6 (n = 2 for each day), and the indicated gene expression was 
analysed by RT-PCR. (d) The body weights of Rag2 − / −  mice administered 
with indomethacin alone (red line) and indomethacin plus PTGER4  
agonist (black line); n = 3 for each group. Error bars represent  ± s.d.  
(e) microscopic observations of the caecum and survival rates of 
indomethacin-administered Rag2 − / −  mice treated with antibiotics (upper 
right image and black line in lower panel) or without antibiotics (upper  
left image and red line in lower panel). scale bar, 200 µm; n = 3 for each 
group. (f) CD4 + CD25high cells (Tregs, 2×105 cells) were transferred to  
4-week-old Rag2 − / −  mice. At 4 weeks after the transfer, mice were fed 
with indomethacin for 8 days. microscopic observations of proximal colons 
and body weights of indomethacin-administered Rag2 − / −  mice transferred 
with Tregs (upper right image and black line in lower panel) or without 
Tregs (upper left image and red line in lower panel) are shown; n = 3 for 
each group. scale bar, 200 µm. Error bars represent  ± s.d.ARTICLE     
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dose-dependently counteracted the suppressive effects of cAMP in 
Socs1 − / −  BMDCs (Fig. 5b). It is notable that IFNγ partially antago-
nized the suppressive effect of PGE2 and cAMP in Socs1 + / +  BMDCs 
(Fig. 5b), although this antagonism was not observed in Stat1 − / −  
BMDCs (Fig. 5c). These data suggest that the antagonistic effect of 
IFNγ/STAT1 pathway against PGE2 and cAMP was amplified in 
Socs1 − / −  BMDCs.
Lastly, we confirmed the relationship among SOCS1, cAMP and 
IL-10/Tregs (Fig. 5d). When we co-cultured Socs1 + / +  BMDCs with 
cAMP and Tregs, the production of IL-12p70 and TNFα was inten-
sively suppressed. The suppressive effect of Treg was diminished 
by anti-IL-10 Ab, indicating that Treg functioned through IL-10 in 
this co-culture experiment (Fig. 5d). Although immunosuppressive 
effect of cAMP was diminished in Socs1 − / −  BMDCs, Tregs potently 
suppressed cytokine production from Socs1 − / −  BMDCs in an IL-
10-dependent manner (Fig. 5d). These phenomena were consistent 
with our in vivo observation that Tregs suppressed colitis in both 
Socs1 − / − Rag2 − / −   mice  and  indomethacin-treated  Rag2 − / −   mice. 
We found that another STAT1-activating cytokine IL-27 and the 
STAT6-activating cytokines, IL-4 and IL-13, also counteracted the 
immunosuppressive effect of cAMP in Socs1 − / −  BMDCs, although 
their effect was not as evident as that of IFNγ (Fig. 6). This may 
explain why IFNγ deficiency could not completely eliminate the 
colitis in Ifng − / − Socs1 − / − Rag2 − / −  mice (Fig. 2b). The involvement 
of STAT6-activating cytokines, especially IL-13, for pathogenesis 
of colitis has been shown in previous studies20,21. Although a recent 
study suggested a role of IL-13 for attenuation of production of 
IFNγ and IL-17, and the resultant colitis due to IL-10 deficiency22, 
our study here suggests a synergistic involvement of IFNγ, IL-4 and 
IL-13 for aggravation of colitis. Collectively, the Treg/IL-10 system   
seems  to  be  more  stable  than  the  PGE2/cAMP  system,  as  the 
former system was not affected by the strong cytokine signalling,   
especially IFNγ/STAT1 signalling, resulting from SOCS1 deficiency. 
The hierarchy among these suppression systems suggested by this 
study is shown in Figure 7.
Discussion
In  this  study,  we  tried  to  clarify  the  relationship  among  Tregs,   
IL-10, PGE2 and SOCS1 in maintaining the tolerance to commensal 
microorganisms. Together with a previous report by Berg et al.23,   
which  showed  severe  indomethacin-induced  colitis  in  Il10 − / −   
mice,  our  study  demonstrated  the  independent  contributions  of 
Treg-derived  IL-10  and  the  PGE2/cAMP  system  for  the  main-
tenance  of  intestinal  tolerance.  These  two  systems  are  regarded   
as safeguarding each other, thus limiting the aggravation of colitis 
(Fig. 7). Our study also suggests that inflammatory cytokine signal-
ling would block the immunosuppressive effect of PGE2 and cAMP 
but not IL-10, and the absence of SOCS1 amplifies the antagonism 
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to PGE2/cAMP. Although we have shown ex vivo that cytokine   
signalling regulation by SOCS1 is required for efficient PGE2-mediated   
suppression of activation of innate immune cells, the contribution 
of the resistance to PGE2/cAMP-mediated suppression in Socs1 − / −  
cells to the development of colitis of Socs1 − / − Rag2 − / −  mice is still 
not  clear.  Because  the  molecular  mechanisms  of  PGE2/cAMP-
mediated innate immune suppression and STAT-dependent inter-
ference to the suppression were not fully resolved, and because we 
did not have a good molecular target, it was difficult for us to rescue 
Socs1 − / − Rag2 − / −  mice from colitis by enhancing the effect of PGE2/
cAMP in a manner that could avoid the effect of enhanced STATs 
signalling. Treatment with a PTGER4 agonist was not suitable for 
this purpose, because activated STATs would block the effect of 
the PTGER4 agonist in Socs1 − / − Rag2 − / −  mice. Therefore, we could 
not provide direct evidence for the link between the two pathways   
in vivo. Nevertheless, the findings that SOCS1 and PGE2/cAMP 
system are indispensable for innate immune system to maintain the 
homeostasis in the colon in the absence of Tregs are interesting. The 
PGE2/cAMP system has not been well recognized as an important 
tolerance mechanism in vivo probably because this system is vulner-
able because of the antagonism by inflammatory cytokines includ-
ing IFNγ and is also masked by a strong suppressive effect of IL-10. 
A pivotal role of the PGE2 suppression system appeared only when 
Tregs or IL-10 are absent. It is well known that the administration 
of COX inhibitors to human IBD patients may increase the risk of 
relapse and worsening of the disease20. Similarly, the administra-
tion of a COX inhibitor has been shown to exacerbate the course of   
dextran  sulphate  sodium  salt-induced  colitis21.  The  IL-10/Treg   
system may not be fully functional in these situations.
Although many mechanisms seem to be involved in the gastro-
protective effect of PGE2 (ref. 24), suppression of the production of 
inflammatory cytokines is probably one of the important mecha-
nisms for protection against colitis. The immunosuppressive activ-
ity of PGE2 largely depends on the production of cAMP from ATP. 
Activation of the PGE2 receptors PTGER2 (EP2) and PTGER4 (EP4) 
usually  upregulates  intracellular  cAMP  level,  whereas  PTGER1 
(EP1)  upregulates  intracellular  Ca2 +   and  PTGER3  (EP3)  down-
regulates cAMP17; the anti-inflammatory effect of PGE2 is, there-
fore, context dependent. As shown previously, cAMP suppresses the 
production of inflammatory cytokines from macrophages and den-
dritic cells in an IL-10-independent manner13,19. Moreover, cAMP 
has been shown to be involved in the induction and function of 
Foxp3 + Tregs25–27. A recent study has shown that cAMP enhances the 
induction of human Th17 cells by PGE2/PTGER2/PTGER4 signal-
ling28. Therefore, the effects of PGE2 and cAMP may be complicated 
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8 a
b
I
L
-
1
2
p
7
0
 
(
n
g
 
m
l
–
1
)
LPS
cAMP
–+++–+++–+++–+++ –+++–+++–+++–+++–+++–+++
+IL-27 +IL-6 +IL-4 +IL-13
T
N
F
α
 
(
n
g
 
m
l
–
1
)
0
2
4
6
8
10
LPS
cAMP
–+++–+++–+++–+++ –+++–+++–+++–+++–+++–+++
+IL-27 +IL-6 +IL-4 +IL-13
33100 33100 3310033100
IL-6 IL-27 IL-4 IL-13
33100 33100 33100 33100
IL-6 IL-27 IL-4 IL-13
cAMP (µM)
0
20
40
60
80
100
(
%
)
 
A
n
t
a
g
o
n
i
s
m
Figure 6 | Select cytokines partially antagonize the cAMP-mediated 
immunosuppression. Socs1 + / +  (5×105 cells per ml; black bars) and 
Socs1 − / −  (5×105 cells per ml; grey bars) BmDCs were stimulated with 
LPs (10 ng ml − 1) and graded concentrations of 8-Br-cAmP (0, 33 and 
100 mm) for 12 h with or without recombinant murine IL-6 (20 ng ml − 1), 
IL-27 (100 ng ml − 1), IL-4 (20 ng ml − 1) and IL-13 (20 ng ml − 1). (a) The levels 
of IL-12p70 and TnFα in the culture supernatant were measured by ELIsA. 
Error bars indicate  + s.d. Cells were stimulated in triplicate wells for each 
condition and s.d. was calculated from the values determined by ELIsA. 
(b) The normalized antagonistic effect (% antagonism) of the indicated 
cytokines against the suppressive effect of cAmP for the production of 
IL-12p70. Data were calculated from a data set shown in panel a. Data are 
representative of two independent experiments (a, b).
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Figure 7 | A model for SOCS1-dependent and -independent mechanism 
of intestinal tolerance. Tolerance to commensal bacteria is regulated by 
two independent pathways: PGE2-cAmP and Treg-IL-10. Inflammatory 
cytokines, especially IFnγ, antagonize PGE2-cAmP-mediated suppression 
for Toll-like receptor signalling. soCs1 negatively regulates IFnγ signalling, 
thus maintaining the PGE2-cAmP-mediated tolerance.ARTICLE     
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in the presence of T cells. Nevertheless, our study established an 
essential role of the PGE2/cAMP system to maintain tolerance to 
commensal bacteria in the intestine.
It is known that not only IL-10 but also TGF-β has an important 
role in intestinal tolerance and suppression of colitis1,28,29. However, 
Tgfb1 − / −  mice as well as Stat3 − / −  mice with SCID or Rag-deficient   
backgrounds  do  not  develop  colitis4–6,30.  We  also  confirmed  that   
Il10 − / − Rag2 − / −  mice do not develop colitis during our observation 
period (2 to 4 months after birth, Supplementary Fig. S2). Although 
Il10 − / − Rag2 − / −   mice  may  still  develop  colitis  with  age,  it  is  clear 
that IL-10 is dispensable for maintenance of intestinal tolerance in 
young adult lymphopenic mice. Thus, it appears that effector T cells 
are required for the development of colitis induced by TGF-β or IL-
10/STAT3 deficiency. In contrast, Socs1 − / −  mice developed colitis, 
especially, on a Rag2 − / −  background, and their colitis was suppressed 
by a transfer of IL-10-producing Tregs. Therefore, the mechanism 
underlying the colitis induced by SOCS1 deficiency is apparently dif-
ferent from those mechanisms underlying the colitis induced by IL-
10 and TGF-β deficiency. The situation of Socs1 − / −  mice was some-
what similar to that of T-bet − / −  mice31. T-bet − / −  mice also develop 
colitis only on a Rag2 − / −  background. However, there are also many 
differences between these two genotypes. In T-bet − / − Rag2 − / −  mice, 
the  dysregulation  of  cytokine  production  was  confined  only  to 
TNFα, but in Socs1 − / − Rag2 − / −  mice, many inflammatory cytokines 
were  upregulated.  Rectal  prolapse  was  frequently  observed  in   
T-bet − / − Rag2 − / −  mice, but was not observed at all in Socs1 − / − Rag2 − / −  
mice.  The  colitis  spread  from  colitic  T-bet − / − Rag2 − / −   mice  to 
healthy T-bet + / + Rag2 − / −  mice, but not from Socs1 − / − Rag2 − / −  mice to   
Socs1 + / + Rag2 − / −  mice. Because the forms of colitis observed in these 
two mice are so different, we speculate that T-bet and SOCS1 differen-
tially regulate the intestinal immune response.
We have shown that STAT1 is antagonistic towards the PGE2/
cAMP pathway. In addition, STAT6-activating cytokines IL-4 and 
IL-13 partly counteracted the immunosuppressive effect of cAMP 
in Socs1 − / −  BMDCs (Fig. 6). However, the molecular mechanisms of 
PGE2/cAMP-mediated immunosuppression and the antagonisms 
by STATs remain to be clarified. Recently, we reported that the tran-
scription factor c-Fos is involved in the mechanism of cAMP-medi-
ated  immunosuppression  in  macrophages19.  Another  group  has 
recently reported that A kinase-anchoring protein 95 (AKAP95), 
which interacts with p105 (nuclear factor-κB1), is responsible for 
cAMP-mediated suppression30. Further study is necessary to clarify 
the mechanisms of suppression and the antagonisms by STATs, the 
balance between which is regulated by SOCS1.
Recent  genome-wide  association  studies  demonstrated  a  sig-
nificant  association  of  single-nucleotide  polymorphisms  within 
the proximity of the PTGER4 gene region, which regulate PTGER4 
expression, with Crohn’s disease32. Polymorphisms in the STAT3 gene 
and JAK2 promoter region also associate with IBD33–36. These stud-
ies suggest that alterations in the strength of PGE2 and JAK/STAT 
signalling can modulate susceptibility to IBD. Our study presented 
here also supports this idea, although we should be very careful in 
translating these results from animal studies to human disease.
We have focused on the role of SOCS1 in the control of intestinal 
inflammation in this study. The dysregulation of cytokine signall-
ings due to the lack of SOCS1 lead to colitis. Lack of SOCS3, another 
important negative feedback regulator of cytokine signallings, on 
the other hand, rendered macrophages and dendritic cells hypore-
sponsive to various Toll-like receptor stimuli because of the hyper-
activation of STAT3 (refs 37, 38), and the macropahge/neutrophil-
specific Socs3-conditional knockout mice were rather resistant to 
DSS-induced colitis37. Interestingly, STAT3-hyperactivated innate 
immune cells are anti-inflammatory in general, whereas STAT3-
hyperactivated T cells, including the T cells devoid of Socs3, are 
more prone to produce IL-17 (ref. 39), and thus mediate inflam-
mation in certain conditions. Studies to clarify the cell type-specific 
roles of SOCS1 and SOCS3 and their relevance in various inflam-
matory settings in vivo are being conducted.
Methods
Mice. Socs1 − / −  mice and Socs1-KOTg mice with a C57BL/6J background had 
been established previously12. Il23a − / −  mice have been described previously40. 
Rag2 − / −  mice, Il10 − / −  mice and Ifng − / −  mice, all with a C57BL/6J background, 
were obtained from The Jackson Laboratory. Several lines of double knockout and 
triple knockout mice were generated by intercrossing. All mice were housed in an 
SPF animal facility at Kyushu University. All experiments using these mice were 
approved by and performed according to the guidelines of the animal ethics com-
mittee of Kyushu University, Fukuoka, Japan.
Flow cytometry and cell sorting. Cells were stained with the indicated fluores-
cein-conjugated Abs at concentrations of 1:200 to 1:1000, and were analysed on a 
FACSCalibur or FACSAria (Becton Dickinson) flow cytometer. All Abs and kits 
used were purchased from eBioscience. For the isolation of Tregs, CD4 +  T cells 
were negatively selected using MACS (Miltenyi Biotec), and CD4 + CD25high7-AAD −  
cells were further purified using FACSAria. The sorted cells, which were used as 
Tregs, were  > 95% CD4 + CD25high, and ~90% of the isolated CD4 + CD25high cells 
expressed Foxp3.
Oral indomethacin administration. Rag2 + / +  and Rag2 − / −  mice were continu-
ously fed with 40 µg ml − 1 (corresponding to ~10 mg kg − 1 per day) of the non-
selective COX inhibitor indomethacin (Nacalai Tesque) in drinking water for 8 
to 10 days. To dissolve the indomethacin completely in water, 0.04% dimethyl 
sulfoxide and 0.2 mM NaOH were also added. The indomethacin solution was 
replaced every 48 h.
Antibiotic treatment and PTGER4 agonist administration. To remove the 
intestinal commensal bacteria, imipenem (50 mg kg − 1 per day; Banyu Pharma-
ceutical) and vancomycin (50 mg kg − 1 per day; Sigma-Aldrich) were continuously 
administered in drinking water. Imipenem  +  vancomycin at this dosage has been 
reported to effectively reduce both the aerobic and anaerobic bacteria residing in 
the colon of mice41. A PTGER4 agonist, ONO-AE1-329 (a generous gift from Ono 
Pharmaceutical), was injected subcutaneously twice a day at a dosage of 4 µg kg − 1 
body weight during the entire period of indomethacin administration.
Histopathological examination. The severity of each colitis case was determined 
according to the criteria shown in Table 1. In preparation for immunohistochemi-
cal examination, frozen cryostat sections were fixed in acetone, blocked with mouse 
serum and incubated with the fluorescein-conjugated monoclonal Abs (1:100). The 
slides were examined through a fluorescence digital microscope (Keyence).
Table 1 | Histological scoring system for chronic colitis.
Histological changes Score
0 1 2 3
Loss of goblet cells none mild/focal numerous and diffuse numerous and diffuse
Crypt abscesses none Few (1 in several sections) A few (1-4 per section) many (≥5 per section)
Hyperaemia in the mucosa none/not evident mild Diffuse Diffuse
Cellular infiltration in the 
lamina propria
none A few moderate/focal numerous and diffuse
Elongation of colonic 
mucosa
normal (≤100%) mild (101–150%) Evident (≥150%) Evident (≥150%)
Epithelial erosion none mild/focal Evident/diffuse Evident/diffuse
For the assessment of the severity of colitis, histological scores of the proximal, middle and distal portion of the colons were determined, as indicated, and the average was calculated.ARTICLE
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Preparations of CMEs. To extract whole molecules of the substances contained 
in the colonic mucosa, 0.2 g wet weight of the mucosal and submucosal layers 
removed from the colons were resuspended in RPMI 1640, frozen at  − 20°C and 
then thawed at 4°C. This freezing and thawing cycle was repeated three times. 
After the third thawing, samples were centrifuged, and the supernatants were 
filtered through a 0.22-µm filter. The liquid thus obtained was used as CME. 
For the comparison of PGE2 levels among tissues, several organs were collected 
from WT mice shortly after the euthanasia, embedded in ice-cold PBS containing 
100 µM indomethacin and frozen and thawed twice. Indomethacin was included 
in the buffer to minimize the de novo production of PGE2 during the experi-
mental procedure. After filtration through a 0.22-µm filter, the concentrations 
of proteins in the supernatants were measured and adjusted to 1 mg ml − 1. PGE2 
levels of the supernatants were determined using ELISA kit (Cayman Chemical).
Biochemical analysis of bone BMDCs. Granulocyte-macrophage colony stimu-
lating factor-induced BMDCs were stimulated with LPS (10 ng ml − 1, Escherichia 
coli serotype 055:B5, Sigma-Aldrich) in the absence or presence of the combi-
nations of cytokines and reagents indicated in the figure legends. The levels of 
IL-12p70 and TNFα produced were measured with an ELISA kit (eBioscience). 
8-Bromoadenosine 3,5′-cyclic monophosphate sodium salt (8-Br-cAMP) was 
purchased from Sigma-Aldrich. PGE2 was purchased from Nacalai Tesque.  
Recombinant murine cytokines were purchased from Peprotech. Anti-IL-10 Ab 
was purchased from eBioscience. A PTGER4 antagonist, ONO-AE3-208 is a gift 
from Ono Pharmaceutical.
Western blot analysis. Anti-tyrosine-phosphorylated STAT1 and anti-serine-
phosphorylated IκBα monoclonal Abs were purchased from Cell Signaling  
Technology. Anti-STAT1, anti-IκBα, anti-c-Fos and anti-p65 Ab were pur-
chased from Santa Cruz Biotechnology. Anti-actin Ab was purchased from 
Sigma-Aldrich.
Reverse transcription PCR analysis. Total RNAs from cell and tissue specimens 
were reverse transcribed and analysed by semi-quantitative PCR or quantitative 
real-time PCR. Quantitative real-time PCR was performed using the Power-
SYBR Green Real-time PCR Master Mix (Applied Biosystems) and the ABI 7000 
Sequence Detector System (Applied Biosystems). The comparative threshold cycle 
(Ct) method was used to calculate the relative expression levels of the target genes 
compared with the internal control (Hprt1). The primer sequences are shown in 
Supplementary Table S1.
Statistical analysis. Statistical analysis was performed using Student’s t-test.  
A P-value  < 0.05 was considered to indicate statistical significance. 
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